Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

GSK plc (GS71)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
20.210 +0.670    +3.43%
11:28:52 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 72,190
  • Bid/Ask: 19.300 / 20.240
  • Day's Range: 19.840 - 20.210
Type:  Equity
Market:  Germany
ISIN:  GB00BN7SWP63 
WKN:  A3DMB5
GSK plc 20.210 +0.670 +3.43%

GS71 Balance Sheet

 
Featured here, the Balance Sheet for GSK plc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 17205 18644 21240 19348
Cash and Short Term Investments 4095 5688 6683 6504
Cash - - - -
Cash & Equivalents 2790 2936 3177 3140
Short Term Investments 1305 450 3506 114
Total Receivables, Net - 6995 8874 7095
Accounts Receivables - Trade, Net 6831 5905 8544 6776
Total Inventory - 5498 5480 5512
Prepaid Expenses - 355 - -
Other Current Assets, Total 117 108 203 237
Total Assets 58511 59005 60862 59461
Property/Plant/Equipment, Total - Net 9867 9957 9454 9315
Property/Plant/Equipment, Total - Gross - 19591 - -
Accumulated Depreciation, Total - -9634 - -
Goodwill, Net 6978 6811 6973 6716
Intangibles, Net 15667 14768 15295 15531
Long Term Investments 1277 1219 1142 1350
Note Receivable - Long Term 460 1081 330 319
Other Long Term Assets, Total 1654 1557 1148 1402
Other Assets, Total 5696 7421 5925 7817
Total Current Liabilities 19846 21068 22390 22108
Accounts Payable 13707 3717 14692 13101
Payable/Accrued - - - -
Accrued Expenses - 4084 - -
Notes Payable/Short Term Debt 1185 893 2520 3635
Current Port. of LT Debt/Capital Leases 1431 1920 2323 2286
Other Current liabilities, Total 3523 10454 2855 3086
Total Liabilities 45282 46210 48243 47302
Total Long Term Debt 15156 15205 15999 15553
Long Term Debt 15156 14154 15999 15553
Capital Lease Obligations - 1051 - -
Deferred Income Tax 288 311 402 500
Minority Interest -611 -552 -514 -532
Other Liabilities, Total 9418 9172 7296 5888
Total Equity 13229 12795 12619 12159
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1348 1348 1348 1348
Additional Paid-In Capital 3471 3451 3450 3450
Retained Earnings (Accumulated Deficit) 7935 7743 7017 6418
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 475 253 804 943
Total Liabilities & Shareholders' Equity 58511 59005 60862 59461
Total Common Shares Outstanding 4078 4056.26 4056 4053
Total Preferred Shares Outstanding - - - -
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email